1st RACE AGAINST ANEMIA

Mexico City, September 30th, 2019 – In the framework of the 53 National Congress of Nephrology that took place from September 25th to 28th in the city of Zacatecas, PROBIOMED presented its high specialty portfolio to health professionals and sponsored the 1st Race against Anemia, which was held on Saturday, September 28th with the participation of more than 100 nephrologists.

Through the sporting event it was sought to unite the medical community in favor of a good cause as, unlike traditional races, the first places were not rewarded, but the participants were encouraged to reach the goal regardless of the time and thus make it possible that, in collaboration with the College of Nephrologists of Mexico and the Mexican Kidney Foundation, PROBIOMED granted 100 treatments to low-income patients with secondary anemia to chronic kidney disease.

About PROBIOMED

PROBIOMED is a Mexican biopharmaceutical company focused on research, development, manufacture and commercialization of pharmaceutical products for human health. We employ more than 800 men and women and operate 3 manufacturing facilities that comply with the strictest national and international regulation.

Since our establishment, in 1970, we have worked to provide millions of people around the globe with high-technology and affordable solutions that help improve health and quality of life. Our portfolio is composed of a wide range of chemical synthesis generics and high-tech biosimilars for the prevention and treatment of autoimmune and chronic-degenerative diseases, hematological and metabolic disorders, as well as malignant neoplasms, among other conditions.